Our publications

Export 218 results:
Author Title Type [ Year(Asc)]
2014
Ventham NT, Kennedy NA, Duffy A, Clark DN, Crowe AM, Knight AD, et al.. Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998-2000 and 2007-2009. Aliment Pharmacol Ther. 2014;39(12):1387-97.
Henderson P, Anderson NH, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(5):637-45.
Guariso G, Gasparetto M, Day AS, Henderson P. Epidemiology and Natural History of IBD in the Paediatric Age. Gastroenterol Res Pract. 2014;2014:432807.
Chen G-B, Lee SHong, Brion M-JA, Montgomery GW, Wray NR, Radford-Smith GL, et al.. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet. 2014;23(17):4710-20.
Chan Y, Lim ET, Sandholm N, Wang SR, McKnight AJayne, Ripke S, et al.. An excess of risk-increasing low-frequency variants can be a signal of polygenic inheritance in complex diseases. Am J Hum Genet. 2014;94(3):437-52.
Degraeuwe PLJ, Beld MPA, Ashorn M, Canani RBerni, Day AS, Diamanti A, et al.. Faecal Calprotectin in Suspected Paediatric Inflammatory Bowel Disease: An Individual Patient Data Meta-Analysis. J Pediatr Gastroenterol Nutr. 2014;.
Kennedy NA, Walker AW, Berry SH, Duncan SH, Farquarson FM, Louis P, et al.. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS One. 2014;9(2):e88982.
Kennedy NA, Lees CW. Letter: Azathioprine-induced pancreatitis and subsequent tolerance of mercaptopurine--authors' reply. Aliment Pharmacol Ther. 2014;39(4):440-1.  (310.55 KB)
Love KA, Henderson P, Garrick V, Barclay AR, McGrogan P, Russell RK. Letter: Epstein-Barr virus status may be especially important in paediatric IBD populations. Aliment Pharmacol Ther. 2014;39(2):231-2.
Jones GR, Kennedy NA, Lees CW, Arnott ID, Satsangi J. Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply: Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply. Aliment Pharmacol Ther. 2014;40(3):323.
Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, et al.. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol. 2014;.
Jones GR, Kennedy NA, Lees CW, Arnott ID, Satsangi J. Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects. Aliment Pharmacol Ther. 2014;39(11):1253-65.
2013
Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, et al.. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353-60.
Jankowski JA, Satsangi J. Barrett's esophagus: evolutionary insights from genomics. Gastroenterology. 2013;144(4):667-9.
Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145(2):293-308.
S Lee H, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al.. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-94.
Van Limbergen J, Russell RK, Nimmo ER, Kabakchiev B, Drummond HE, Satsangi J, et al.. Haplotype-tagging analysis of common variants of the IL23R gene demonstrates gene-wide extent of association with IBD. Inflamm Bowel Dis. 2013;19(6):E79-80.
Lee JC, Espéli M, Anderson CA, Linterman MA, Pocock JM, Williams NJ, et al.. Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell. 2013;155(1):57-69.
Stevens C, Henderson P, Nimmo ER, Soares DC, Dogan B, Simpson KW, et al.. The intermediate filament protein, vimentin, is a regulator of NOD2 activity. Gut. 2013;62(5):695-707.
Hunt KA, Mistry V, Bockett NA, Ahmad T, Ban M, Barker JN, et al.. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature. 2013;498(7453):232-5.
Kennedy NA, Rodgers A, Altus R, McCormick R, Wundke R, Wigg AJ. Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study. Intern Med J. 2013;43(7):772-7.
Van Limbergen J, Geddes K, Henderson P, Russell RK, Drummond HE, Satsangi J, et al.. Paneth cell marker CD24 in NOD2 knockout organoids and in inflammatory bowel disease (IBD). Gut. 2013;.
Kennedy NA, Asser TL, Mountifield RE, Doogue MP, Andrews JM, Bampton PA. Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Intern Med J. 2013;43(3):278-86.
Kennedy NA, Rhatigan E, Arnott IDR, Noble CL, Shand AG, Satsangi J, et al.. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis. Aliment Pharmacol Ther. 2013;38(10):1255-66.

Pages